HHS
HARTE HANKS INC
Overview
Harte Hanks provides business outsourcing services across data, marketing, sales, customer care, fulfillment, and logistics to B2B and B2C companies globally.
HARTE HANKS INC is a Industrials company operating in Conglomerates with a $17.9M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 5, 2026).
15 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q3 FY2024Earnings2024-11-14
- Q2 FY2024Earnings2024-08-085 Q&A exchanges
- Q1 FY2024Earnings2024-05-096 Q&A exchanges
- Q4 FY2023Earnings2024-03-145 Q&A exchanges
- Q3 FY2023Earnings2023-11-095 Q&A exchanges
- Q2 FY2023Earnings2023-08-108 Q&A exchanges
- Q1 FY2023Earnings2023-05-0313 Q&A exchanges
- Q4 FY2022Earnings2023-03-0716 Q&A exchanges
- Q3 FY2022Earnings2022-11-1016 Q&A exchanges
- Q2 FY2022Earnings2022-08-1112 Q&A exchanges
- Q1 FY2022Earnings2022-05-129 Q&A exchanges
- Q4 FY2021Earnings2022-02-242 Q&A exchanges
- Q3 FY2021Earnings2021-11-1110 Q&A exchanges
- Q2 FY2021Earnings2021-08-1211 Q&A exchanges
- Q1 FY2021Earnings2021-05-195 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-05EPS— vs ——Rev— vs ——EODHD
- Q1 FY20262026-05-14EPS$-0.08 vs ——Rev$37.3M vs ——EODHD
- Q4 FY20252026-03-11EPS$0.30 vs $0.52-42.9%Rev$39.9M vs ——EODHD
- Q3 FY20252025-11-12EPS$-0.31 vs $0.41-100.0%Rev$39.5M vs ——EODHD
- Q2 FY20252025-08-07EPS$-0.05 vs $0.22-100.0%Rev$38.6M vs ——EODHD
- Q1 FY20252025-05-06EPS$-0.05 vs $0.15-100.0%Rev$41.6M vs ——EODHD
- Q4 FY20242025-03-11EPS$-0.33 vs $0.31-100.0%Rev$47.1M vs ——EODHD
- Q3 FY20242024-11-13EPS$0.02 vs $0.10-80.0%Rev$47.6M vs ——EODHD
- Q2 FY20242024-08-07EPS$1.41 vs $0.05+100.0%Rev$45.0M vs ——EODHD
- Q1 FY20242024-05-09EPS$-0.02 vs $-0.04+50.0%Rev$45.4M vs ——EODHD
- Q4 FY20232024-03-13EPS$0.50 vs $0.12+100.0%Rev$49.5M vs ——EODHD
- Q3 FY20232023-11-08EPS$0.08 vs $0.18-55.6%Rev$47.1M vs ——EODHD
- Q2 FY20232023-08-09EPS$0.08 vs $0.20-60.0%Rev$47.8M vs ——EODHD
- Q1 FY20232023-05-01EPS$-0.11 vs $0.21-100.0%Rev$47.1M vs ——EODHD
- Q4 FY20222023-03-06EPS$2.70 vs $0.10+100.0%Rev$54.8M vs ——EODHD
- Q3 FY20222022-11-09EPS$0.83 vs $0.41+100.0%Rev$53.9M vs ——EODHD
- Q2 FY20222022-08-10EPS$0.52 vs $0.28+85.7%Rev$48.6M vs ——EODHD
- Q1 FY20222022-05-11EPS$0.39 vs $0.05+100.0%Rev$49.1M vs ——EODHD
- Q4 FY20212022-02-23EPS$0.20 vs $0.18+11.1%Rev$52.0M vs ——EODHD
- Q3 FY20212021-11-10EPS$0.52 vs $0.04+100.0%Rev$49.6M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | — | — | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-14 | $-0.08 | — | — | $37.3M | — | — | EODHD |
| Q4 FY2025 | 2026-03-11 | $0.30 | $0.52 | -42.9% | $39.9M | — | — | EODHD |
| Q3 FY2025 | 2025-11-12 | $-0.31 | $0.41 | -100.0% | $39.5M | — | — | EODHD |
| Q2 FY2025 | 2025-08-07 | $-0.05 | $0.22 | -100.0% | $38.6M | — | — | EODHD |
| Q1 FY2025 | 2025-05-06 | $-0.05 | $0.15 | -100.0% | $41.6M | — | — | EODHD |
| Q4 FY2024 | 2025-03-11 | $-0.33 | $0.31 | -100.0% | $47.1M | — | — | EODHD |
| Q3 FY2024 | 2024-11-13 | $0.02 | $0.10 | -80.0% | $47.6M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $1.41 | $0.05 | +100.0% | $45.0M | — | — | EODHD |
| Q1 FY2024 | 2024-05-09 | $-0.02 | $-0.04 | +50.0% | $45.4M | — | — | EODHD |
| Q4 FY2023 | 2024-03-13 | $0.50 | $0.12 | +100.0% | $49.5M | — | — | EODHD |
| Q3 FY2023 | 2023-11-08 | $0.08 | $0.18 | -55.6% | $47.1M | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $0.08 | $0.20 | -60.0% | $47.8M | — | — | EODHD |
| Q1 FY2023 | 2023-05-01 | $-0.11 | $0.21 | -100.0% | $47.1M | — | — | EODHD |
| Q4 FY2022 | 2023-03-06 | $2.70 | $0.10 | +100.0% | $54.8M | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $0.83 | $0.41 | +100.0% | $53.9M | — | — | EODHD |
| Q2 FY2022 | 2022-08-10 | $0.52 | $0.28 | +85.7% | $48.6M | — | — | EODHD |
| Q1 FY2022 | 2022-05-11 | $0.39 | $0.05 | +100.0% | $49.1M | — | — | EODHD |
| Q4 FY2021 | 2022-02-23 | $0.20 | $0.18 | +11.1% | $52.0M | — | — | EODHD |
| Q3 FY2021 | 2021-11-10 | $0.52 | $0.04 | +100.0% | $49.6M | — | — | EODHD |
Source: EODHD. HHS reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks HHS's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 3 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2024 | $4.09 | $3.80 | +7.7% | -0.8% | +2.1% |
| Q4 FY2024 | $4.35 | $4.05 | +7.3% | -3.5% | -5.6% |
| Q3 FY2024 | $4.37 | $4.03 | +8.4% | +4.3% | +4.9% |
| Q2 FY2024 | $4.22 | $4.07 | +3.8% | +0.4% | -0.3% |
| Q1 FY2023 | $3.91 | $3.86 | +1.4% | +5.4% | +6.8% |
| Q4 FY2023 | $4.13 | $3.90 | +5.9% | -2.8% | -2.0% |
| Q3 FY2023 | $4.56 | $4.15 | +9.9% | +3.0% | +0.9% |
| Q2 FY2023 | $4.16 | $4.16 | 0.0% | +3.6% | +3.2% |
| Q1 FY2022 | $4.41 | $3.99 | +10.5% | -3.3% | -1.8% |
| Q4 FY2022 | $4.21 | $4.14 | +1.8% | -1.3% | +0.9% |
Guidance change history
Sample- Q1 FY2024Raised2024-04-15
- Q4 FY2024Raised2024-13-15
- Q3 FY2024Raised2024-10-15
- Q2 FY2024Maintained2024-07-15
- Q1 FY2023Maintained2023-04-15
- Q4 FY2023Raised2023-13-15
- Q3 FY2023Raised2023-10-15
- Q2 FY2023Maintained2023-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- David A GarrisonCFO2 yr 5 mo5 callsCurrentSample
CFO since 2024 • 1/2 beats (50%) • last guidance raise Q1 FY2024
- Robert T WymanGeneral Counsel2 yr 3 mono recorded callsCurrentSample
OTHER since 2024 • 1/2 beats (50%) • last guidance raise Q1 FY2024
- Kirk A DavisCEO9 mo6 callsFormerSample
CEO since 2023 • 1/4 beats (25%) • last guidance raise Q2 FY2024
- David Scott FisherPresident0 mono recorded callsFormerSample
PRESIDENT since 2025 • 2/2 beats (100%) • last guidance cut Q3 FY2024
Peers
Other companies in Industrials
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for HHS.
$ curl https://api.spokenalpha.com/v1/companies/HHSFAQ
Frequently asked about HHS
Where can I find HARTE HANKS INC's (HHS) earnings call transcripts?
Spoken Alpha indexes HHS's earnings call transcripts at https://spokenalpha.com/companies/HHS. Each call links to attributed speakers and parsed analyst Q&A. HARTE HANKS INC's own investor relations page is at https://investors.hartehanks.com/.
When was HARTE HANKS INC's most recent earnings call?
HARTE HANKS INC (HHS) held its most recent earnings call on 2024-11-14, covering fiscal Q3 2024.
What sector is HHS in?
HARTE HANKS INC (HHS) operates in the Industrials sector (Conglomerates industry).